An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy

The authors wish to thank Professor Hider (King’s College London, UK) for synthesising CP94. The financial support of the Medical Research Council (MRC, UK) and Killing Cancer (UK) is very gratefully acknowledged.